Page last updated: 2024-10-16

carbon monoxide and Hyperinsulinism

carbon monoxide has been researched along with Hyperinsulinism in 1 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jimenez-Feltstrom, J1
Salehi, A1
Meidute Abaraviciene, S1
Henningsson, R1
Lundquist, I1

Other Studies

1 other study available for carbon monoxide and Hyperinsulinism

ArticleYear
Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Regulatory peptides, 2011, Oct-10, Volume: 170, Issue:1-3

    Topics: Animals; Blood Glucose; Carbon Monoxide; Diabetes Mellitus, Type 2; Enzyme Assays; Female; Glucagon;

2011